Sept 16 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 16
points lower at 6,089 on Wednesday, according to financial bookmakers.
* AstraZeneca: The U.S. Food and Drug Administration said on Tuesday
AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is still
on hold, and it was working with the company to figure out if there was a
significant safety issue or not. * PREMIER OIL: Premier Oil Plc PMO.L said on Tuesday it was in talks with
private-equity backed oil producer Chrysaor and several other parties on
alternative deals to secure long-term debt refinancing. * GOLD: Gold prices held steady on Wednesday as investors awaited the
outcome of the U.S. Federal Reserve's policy meeting, hoping for details of the
central bank's plans to balance interest rates against its inflation target.
* OIL: Oil prices rose on Wednesday, extending gains from the previous
session, as a hurricane disrupted U.S. offshore oil and gas production and an
industry report showed a big drop in U.S. crude stockpiles. * The UK blue-chip index .FTSE closed 1.3% higher on Tuesday as miners
were helped by upbeat Chinese industrial output data, while the mid-cap index
was supported by insurers on the prospect of lower-than-expected COVID-19
payouts. UK CORPORATE DIARY:
Galliford Try Plc GFRD.L FY results
Redde Northgate Plc REDD.L FY results
Pan African Resources PAFR.L FY results
accesso Technology Group Plc ACSO.L HY results
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB